Logo image of COSM

COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

NASDAQ:COSM - US2214133058 - Common Stock

0.636 USD
-0.01 (-2%)
Last: 9/8/2025, 12:18:08 PM
Fundamental Rating

1

Overall COSM gets a fundamental rating of 1 out of 10. We evaluated COSM against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of COSM have multiple concerns. COSM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
COSM had negative earnings in 4 of the past 5 years.
COSM had a negative operating cash flow in each of the past 5 years.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of COSM (-37.29%) is worse than 89.11% of its industry peers.
Looking at the Return On Equity, with a value of -82.19%, COSM is doing worse than 76.24% of the companies in the same industry.
Industry RankSector Rank
ROA -37.29%
ROE -82.19%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 9.39%, COSM is doing worse than 74.26% of the companies in the same industry.
COSM's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for COSM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

1

2. Health

2.1 Basic Checks

COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COSM has been increased compared to 1 year ago.
COSM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COSM has a worse debt to assets ratio.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.29, we must say that COSM is in the distress zone and has some risk of bankruptcy.
COSM's Altman-Z score of -2.29 is on the low side compared to the rest of the industry. COSM is outperformed by 85.15% of its industry peers.
COSM has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, COSM is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -2.29
ROIC/WACCN/A
WACC6.84%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

COSM has a Current Ratio of 1.05. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
COSM has a Current ratio of 1.05. This is in the lower half of the industry: COSM underperforms 70.30% of its industry peers.
A Quick Ratio of 0.87 indicates that COSM may have some problems paying its short term obligations.
COSM's Quick ratio of 0.87 is on the low side compared to the rest of the industry. COSM is outperformed by 71.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.87
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.63% over the past year.
Looking at the last year, COSM shows a decrease in Revenue. The Revenue has decreased by -3.69% in the last year.
Measured over the past years, COSM shows a small growth in Revenue. The Revenue has been growing by 6.52% on average per year.
EPS 1Y (TTM)47.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.66%
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%-5.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
COSM is valuated quite expensively with a Price/Forward Earnings ratio of 62.35.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COSM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, COSM is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 62.35
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

COSM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

COSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSMOS HEALTH INC

NASDAQ:COSM (9/8/2025, 12:18:08 PM)

0.636

-0.01 (-2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-12 2025-11-12
Inst Owners9.31%
Inst Owner Change-63.04%
Ins Owners31.08%
Ins Owner Change13.04%
Market Cap19.21M
Analysts82.86
Price Target3.06 (381.13%)
Short Float %3.23%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.55%
Min Revenue beat(2)-13.27%
Max Revenue beat(2)-3.83%
Revenue beat(4)0
Avg Revenue beat(4)-11.32%
Min Revenue beat(4)-15.09%
Max Revenue beat(4)-3.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 62.35
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)0.01
Fwd EY1.6%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS1.77
BVpS0.86
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.29%
ROE -82.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.39%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 95.88%
Cap/Sales 2.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.87
Altman-Z -2.29
F-Score5
WACC6.84%
ROIC/WACCN/A
Cap/Depr(3y)567.53%
Cap/Depr(5y)400.27%
Cap/Sales(3y)5.71%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.66%
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%-5.98%
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.2%
OCF growth 3YN/A
OCF growth 5YN/A